ABNORMAL PRESSURE NATRIURESIS IN HYPERTENSION
ABNORMAL PRESSURE NATRIURESIS IN HYPERTENSION
批准号:
2459901
负责人:
Jacqueline Novak
金额:
$2.86万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-08-01 至
中文摘要
有相当多的证据支持这种理论,即某种形式的
英文摘要
There is considerable evidence to support the theory that some form of
renal dysfunction plays a role in the development and maintenance of
hypertension. In several forms of genetic hypertension, a common defect
has been identified in the pressure natriuresis relationship. The defect
in hypertensive animals is partly due to an inability to transmit renal
perfusion pressure into the renal interstitium. The goal of this proposal
is to examine possible mechanism that mediate this intrarenal
abnormality.
In recent studies, endothelin (ET) and nitric oxide (NO) have been shown
to have significant effects on renal excretory function and that
synthesis of these factors may be altered in hypertension. The main
objective of this proposal is to test the hypothesis that the inability
to transmit the renal perfusion pressure into the renal interstitium is
due to abnormalities in the renal autocoids such as NO and ET. A variety
of techniques including microcirculatory, whole kidney, and whole animal
will be used to examine the roles of ET and NO in contributing to the
abnormal pressure natriuresis in different models of hypertension. The
questions that will be addressed are: 1) Is the inability to transmit
renal perfusion pressure into the renal interstitium in Dahl S rats due
to a decrease in NO synthesis? 2) By what mechanism does L-arginine
restore the normal pressure natriuresis relationship in Dahl S rats? Does
L-arginine improve transmission of RPP into the renal interstitium by
affecting medullary hemodynamics? 3) Does chronic renal interstitial
infusion of a NO synthase inhibitor into Dahl R rats render them salt-
sensitive? 4) What role does ET play in the abnormal pressure
natriuresis in various forms of hypertension? Does infusion of an ET
receptor antagonist improve the transmission of RPP into the renal
interstitium? 5) What role does ET lay in the progression of
hypertension: Does chronic infusion of an ET receptor antagonist lead to
long-term reductions in arterial pressure in various forms of
hypertension?
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Role of nitric oxide in modulating the long-term renal and hypertensive actions of norepinephrine.
一氧化氮在调节去甲肾上腺素的长期肾脏和高血压作用中的作用。
DOI:
10.1161/01.hyp.29.1.205
发表时间:
1997
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
[Granger,J, Schnackenberg,C, Novak,J, Tucker,B, Miller,T, Morgan,S, Kassab,S]
通讯作者:
Kassab,S
Reduced sensitivity of the renal circulation to angiotensin II in pregnant rats.
妊娠大鼠肾循环对血管紧张素 II 的敏感性降低。
DOI:
10.1161/01.hyp.30.3.580
发表时间:
1997
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
[Novak,J, Reckelhoff,J, Bumgarner,L, Cockrell,K, Kassab,S, Granger,JP]
通讯作者:
Granger,JP
Relaxin: A Novel HRT for Prevention of Cardiac Disease
-
批准号:8180696
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2011
-
负责人:Jacqueline Novak
-
依托单位:
ABNORMAL PRESSURE NATRIURESIS IN HYPERTENSION
-
批准号:2214419
-
项目类别:
-
资助金额:$2.37万
-
财政年份:1996
-
负责人:Jacqueline Novak
-
依托单位:
ABNORMAL PRESSURE NATRIURESIS IN HYPERTENSION
-
批准号:2214418
-
项目类别:
-
资助金额:$2.26万
-
财政年份:1995
-
负责人:Jacqueline Novak
-
依托单位:
海外基金